Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.02 - $1.83 $208,155 - $373,455
-204,074 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.06 - $2.1 $47,406 - $93,918
44,723 Added 28.07%
204,074 $288,000
Q4 2021

Feb 14, 2022

BUY
$2.05 - $3.2 $243,785 - $380,544
118,920 Added 294.13%
159,351 $327,000
Q3 2021

Nov 15, 2021

SELL
$2.54 - $4.07 $37,617 - $60,276
-14,810 Reduced 26.81%
40,431 $125,000
Q2 2021

Aug 16, 2021

BUY
$2.57 - $4.85 $141,969 - $267,918
55,241 New
55,241 $225,000
Q2 2020

Aug 14, 2020

SELL
$1.69 - $4.2 $63,758 - $158,453
-37,727 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.26 - $3.38 $47,536 - $127,517
37,727 New
37,727 $100,000
Q4 2019

Feb 14, 2020

SELL
$0.86 - $1.44 $17,569 - $29,419
-20,430 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.21 - $1.59 $4,789 - $6,293
3,958 Added 24.03%
20,430 $25,000
Q2 2019

Aug 14, 2019

SELL
$1.25 - $3.14 $102,062 - $256,381
-81,650 Reduced 83.21%
16,472 $25,000
Q1 2019

May 15, 2019

BUY
$2.79 - $4.09 $273,760 - $401,318
98,122 New
98,122 $290,000
Q3 2018

Nov 14, 2018

SELL
$6.86 - $9.97 $84,693 - $123,089
-12,346 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$2.88 - $8.67 $35,556 - $107,039
12,346 New
12,346 $85,000
Q1 2018

May 15, 2018

SELL
$2.92 - $3.81 $292,195 - $381,255
-100,067 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$2.99 - $4.85 $191,859 - $311,209
64,167 Added 178.74%
100,067 $307,000
Q3 2017

Nov 14, 2017

BUY
$3.01 - $5.41 $108,058 - $194,219
35,900
35,900 $169,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $825M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.